Acadia Healthcare Company, Inc. (ACHC)
NASDAQ: ACHC · Real-Time Price · USD
37.90
-0.69 (-1.79%)
Dec 20, 2024, 4:00 PM EST - Market closed
Acadia Healthcare Company Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for ACHC stock have an average target of 72.13, with a low estimate of 43 and a high estimate of 92. The average target predicts an increase of 90.32% from the current stock price of 37.90.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ACHC stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Hold | 4 | 4 | 3 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 9 | 8 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades $45 → $75 | Hold → Strong Buy | Upgrades | $45 → $75 | +97.89% | Dec 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $52 | Hold | Reiterates | $52 | +37.20% | Dec 10, 2024 |
| Barclays | Barclays | Buy Maintains $76 → $43 | Buy | Maintains | $76 → $43 | +13.46% | Nov 22, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $94 → $64 | Buy | Maintains | $94 → $64 | +68.87% | Nov 18, 2024 |
| Keybanc | Keybanc | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Oct 11, 2024 |
Financial Forecast
Revenue This Year
3.22B
from 2.93B
Increased by 10.05%
Revenue Next Year
3.52B
from 3.22B
Increased by 9.22%
EPS This Year
3.46
from -0.24
EPS Next Year
3.66
from 3.46
Increased by 5.71%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 3.3B | 3.7B | 4.1B | |
| Avg | 3.2B | 3.5B | 3.9B | |
| Low | 3.1B | 3.3B | 3.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 13.4% | 15.5% | 16.8% | |
| Avg | 10.0% | 9.2% | 9.4% | |
| Low | 5.6% | 2.1% | 3.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 3.62 | 4.40 | 4.79 | |
| Avg | 3.46 | 3.66 | 4.02 | |
| Low | 3.28 | 3.10 | 3.40 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | 27.1% | 30.8% | |
| Avg | - | 5.7% | 9.9% | |
| Low | - | -10.6% | -7.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.